Chewing Up the Months and Spitting Them Out

Brain cancer is...

[Still] Loving Every Day

...16 months old today.

The median overall survival (OS) rate for GBM patients who have standard of care treatment (surgery, chemotherapy, and radiation) is 16 months.  Today Darrell treated that statistic as if it were nothing but a tasty morsel! 

For GBM patients getting standard of care treatment plus Optune, the median overall survival increases by 4.8 months to 20.8.  However, you know our Big D.  

The other survival rate calculated is progression free survival (PFS). For standard of care patients in this linked study, median PFS was 4 months, meaning that four months was the average time for a recurrence. For Optune users, PFS increased to 6.7 months.  Therefore, because Darrell is progression free at 16 months, he is progression-free 11 months longer than the median patient using Optune. Whoo!  Whoo!

Darrell is next aiming his sights on 21 months, then: the median overall survival for Optune users.  Twenty one months:  Coming in hot!

Bonus Content

Darrell joined me on campus today to work his usual magic on things like my power strips.  We were greeted by such warmth and kindness by the people in my department that we felt very well loved [again].  Thanks, EDEL!

CSUF Poppies

CSUF Bee